Literature DB >> 8294920

Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding.

R V Bhat1, M J Marks, A C Collins.   

Abstract

It is well established that chronic nicotine treatment produces a dose-dependent increase in high-affinity L-[3H]nicotine binding. This increase may be due to chronic desensitization of the receptor. Sophisticated kinetic analyses of high-affinity nicotine binding to rat brain have demonstrated that the association rate is biphasic; the fast phase may represent binding to a high-affinity predesensitized state and the slow phase may represent binding to a lower affinity ground state that then isomerizes to form the high-affinity binding site. This isomerization presumably leads to receptor desensitization. The studies reported here assessed whether binding to mouse brain nicotinic receptors shows these same properties and whether chronic intravenous infusion of nicotine results in changes in these kinetic properties. The results obtained indicate that mouse brain nicotine binding also shows biphasic association kinetics and uniphasic dissociation kinetics, which supports the assertion that the receptor exists in two interconvertible states. However, unlike other results obtained with rat brain, the rate of the slow association process did not change with ligand concentration. Chronic infusion resulted in a dose-dependent increase in L-[3H]nicotine binding, but the ratio of fast/slow phases of binding was not changed by these treatments. These results suggest that chronic infusion does not alter measurably the kinetics of nicotinic receptor binding when measured in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294920     DOI: 10.1046/j.1471-4159.1994.62020574.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function.

Authors:  B Buisson; D Bertrand
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

2.  86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.

Authors:  Michael J Marks; Natalie M Meinerz; Robert W B Brown; Allan C Collins
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

Review 3.  The road to discovery of neuronal nicotinic cholinergic receptor subtypes.

Authors:  Allan C Collins; Outi Salminen; Michael J Marks; Paul Whiteaker; Sharon R Grady
Journal:  Handb Exp Pharmacol       Date:  2009
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.